Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Interventional × Infusions, Parenteral × Clear all

Phase

Status

Completed 2 Terminated 1 Suspended 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Ovarian Epithelial 1

Interventions

Cyclophosphamide 342 Carboplatin 289 pembrolizumab 272 Gemcitabine 271 Cisplatin 265 Radiotherapy 253 Paclitaxel 251 Docetaxel 247 Bevacizumab 213 Rituximab 201 Capecitabine 191 Nivolumab 180 Dexamethasone 173 Fluorouracil 170 fludarabine 157 Oxaliplatin 150 Doxorubicin 136 Leucovorin 127 Irinotecan 127 Pemetrexed 123 Etoposide 123 Cytarabine 122 fludarabine phosphate 112 Bortezomib 111 Lenalidomide 107 Filgrastim 106 Cetuximab 104 Erlotinib Hydrochloride 99 Temozolomide 94 Trastuzumab 92

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00889733 2024-03-26

OVHM-01

University Health Network, Toronto

Phase 1/2 Terminated

Carcinoma, Ovarian Epithelial

Data powered by HemOnc (CC BY 4.0) Colophon ⚡